Cite
HARVARD Citation
Hallakou‐Bozec, S. et al. (2021). Mechanism of action of Imeglimin: A novel therapeutic agent for type 2 diabetes. Diabetes, obesity & metabolism. 23 (3), pp. 664-673. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Hallakou‐Bozec, S. et al. (2021). Mechanism of action of Imeglimin: A novel therapeutic agent for type 2 diabetes. Diabetes, obesity & metabolism. 23 (3), pp. 664-673. [Online].